{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:52:09Z","timestamp":1790697129151,"version":"4.1.0"},"reference-count":47,"publisher":"Japan Society for Cell Biology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Struct. Funct."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1247\/csf.23066","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T22:11:32Z","timestamp":1702073492000},"page":"1-10","source":"Crossref","is-referenced-by-count":4,"title":["Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease"],"prefix":"10.1247","volume":"49","author":[{"given":"Asuka","family":"Hamamoto","sequence":"first","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Kita","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddabasave Gowda","family":"B. Gowda","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"},{"name":"Graduate School of Global Food Resources, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takatsu","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Arita","sequence":"additional","affiliation":[{"name":"Laboratory for Metabolomics, RIKEN Center of Integrative Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ping","family":"Hui","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Won","family":"Shin","sequence":"additional","affiliation":[{"name":"Graduate School of Pharmaceutical Science, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"333","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arends, M., van Dussen, L., Biegstraaten, M., and Hollak, C.E. 2013. Malignancies and monoclonal gammopathy in Gaucher disease; A systematic review of the literature. Br. J. Haematol., 161: 832\u2013842.","DOI":"10.1111\/bjh.12335"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Arevalo, N.B., Lamaizon, C.M., Cavieres, V.A., Burgos, P.V., Alvarez, A.R., Yanez, M.J., and Zanlungo, S. 2022. Neuronopathic Gaucher disease: Beyond lysosomal dysfunction. Front. Mol. Neurosci., 15: 934820.","DOI":"10.3389\/fnmol.2022.934820"},{"key":"3","doi-asserted-by":"crossref","unstructured":"B. Gowda, S.G., Tsukui, T., Fuda, H., Minami, Y., Gowda, D., Chiba, H., and Hui, S.P. 2021. Docosahexaenoic acid esters of hydroxy fatty acid is a novel activator of NRF2. Int. J. Mol. Sci., 22: 7598.","DOI":"10.3390\/ijms22147598"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bosch, M.E. and Kielian, T. 2015. Neuroinflammatory paradigms in lysosomal storage diseases. Front. Neurosci., 9: 417.","DOI":"10.3389\/fnins.2015.00417"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Boya, P. and Kroemer, G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene, 27: 6434\u20136451.","DOI":"10.1038\/onc.2008.310"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Brady, R.O., Kanfer, J.N., and Shapiro, D. 1965. Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease. Biochem. Biophys. Res. Commun., 18: 221\u2013225.","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cox, T.M. and Schofield, J.P. 1997. Gaucher\u2019s disease: Clinical features and natural history. Baillieres Clin. Haematol., 10: 657\u2013689.","DOI":"10.1016\/S0950-3536(97)80033-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dehay, B., Bove, J., Rodriguez-Muela, N., Perier, C., Recasens, A., Boya, P., and Vila, M. 2010. Pathogenic lysosomal depletion in Parkinson\u2019s disease. J. Neurosci., 30: 12535\u201312544.","DOI":"10.1523\/JNEUROSCI.1920-10.2010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dekker, N., van Dussen, L., Hollak, C.E., Overkleeft, H., Scheij, S., Ghauharali, K., van Breemen, M.J., Ferraz, M.J., Groener, J.E., Maas, M., Wijburg, F.A., Speijer, D., Tylki-Szymanska, A., Mistry, P.K., Boot, R.G., and Aerts, J.M. 2011. Elevated plasma glucosylsphingosine in Gaucher disease: Relation to phenotype, storage cell markers, and therapeutic response. Blood, 118: e118\u2013e127.","DOI":"10.1182\/blood-2011-05-352971"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Do, J., McKinney, C., Sharma, P., and Sidransky, E. 2019. Glucocerebrosidase and its relevance to Parkinson disease. Mol. Neurodegener., 14: 36.","DOI":"10.1186\/s13024-019-0336-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Emmerson, B.T., Cross, M., Osborne, J.M., and Axelsen, R.A. 1990. Reaction of MDCK cells to crystals of monosodium urate monohydrate and uric acid. Kidney Int., 37: 36\u201343.","DOI":"10.1038\/ki.1990.5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Farfel-Becker, T., Vitner, E.B., and Futerman, A.H. 2011. Animal models for Gaucher disease research. Dis. Model Mech., 4: 746\u2013752.","DOI":"10.1242\/dmm.008185"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ferraz, M.J., Kallemeijn, W.W., Mirzaian, M., Herrera Moro, D., Marques, A., Wisse, P., Boot, R.G., Willems, L.I., Overkleeft, H.S., and Aerts, J.M. 2014. Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses. Biochim. Biophys. Acta, 1841: 811\u2013825.","DOI":"10.1016\/j.bbalip.2013.11.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Folch, J., Lees, M., and Sloane Stanley, G.H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem., 226: 497\u2013509.","DOI":"10.1016\/S0021-9258(18)64849-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Fuller, M., Rozaklis, T., Lovejoy, M., Zarrinkalam, K., Hopwood, J.J., and Meikle, P.J. 2008. Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease. Mol. Genet. Metab., 93: 437\u2013443.","DOI":"10.1016\/j.ymgme.2007.11.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and Latz, E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol., 9: 847\u2013856.","DOI":"10.1038\/ni.1631"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Horowitz, M. and Zimran, A. 1994. Mutations causing Gaucher disease. Hum. Mutat., 3: 1\u201311.","DOI":"10.1002\/humu.1380030102"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kroemer, G. and Jaattela, M. 2005. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer, 5: 886\u2013897.","DOI":"10.1038\/nrc1738"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lachmann, R.H., Grant, I.R., Halsall, D., and Cox, T.M. 2004. Twin pairs showing discordance of phenotype in adult Gaucher\u2019s disease. QJM, 97: 199\u2013204.","DOI":"10.1093\/qjmed\/hch036"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Mistry, P.K., Taddei, T., vom Dahl, S., and Rosenbloom, B.E. 2013. Gaucher disease and malignancy: A model for cancer pathogenesis in an inborn error of metabolism. Crit. Rev. Oncog., 18: 235\u2013246.","DOI":"10.1615\/CritRevOncog.2013006145"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Mistry, P.K., Lopez, G., Schiffmann, R., Barton, N.W., Weinreb, N.J., and Sidransky, E. 2017. Gaucher disease: Progress and ongoing challenges. Mol. Genet. Metab., 120: 8\u201321.","DOI":"10.1016\/j.ymgme.2016.11.006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mobarak, E., Haversen, L., Manna, M., Rutberg, M., Levin, M., Perkins, R., Rog, T., Vattulainen, I., and Boren, J. 2018. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS\/TLR4 complex in silico. Sci. Rep., 8: 13600.","DOI":"10.1038\/s41598-018-31926-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nagata, M., Izumi, Y., Ishikawa, E., Kiyotake, R., Doi, R., Iwai, S., Omahdi, Z., Yamaji, T., Miyamoto, T., Bamba, T., and Yamasaki, S. 2017. Intracellular metabolite beta-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity. Proc. Natl. Acad. Sci. USA, 114: E3285\u2013E3294.","DOI":"10.1073\/pnas.1618133114"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Navarro-Romero, A., Fernandez-Gonzalez, I., Riera, J., Montpeyo, M., Albert-Bayo, M., Lopez-Royo, T., Castillo-Sanchez, P., Carnicer-Caceres, C., Arranz-Amo, J.A., Castillo-Ribelles, L., Pradas, E., Casas, J., Vila, M., and Martinez-Vicente, M. 2022. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. NPJ Parkinsons Dis., 8: 126.","DOI":"10.1038\/s41531-022-00397-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ono, H., Ohta, R., Kawasaki, Y., Niwa, A., Takada, H., Nakahata, T., Ohga, S., and Saito, M.K. 2018. Lysosomal membrane permeabilization causes secretion of IL-1beta in human vascular smooth muscle cells. Inflamm. Res., 67: 879\u2013889.","DOI":"10.1007\/s00011-018-1178-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Patel, S., Radhakrishnan, D., Kumari, D., Bhansali, P., and Setty, S.R.G. 2023. Restoration of beta-GC trafficking improves the lysosome function in Gaucher disease. Traffic, 24: 489\u2013503.","DOI":"10.1111\/tra.12911"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Paz, I., Sachse, M., Dupont, N., Mounier, J., Cederfur, C., Enninga, J., Leffler, H., Poirier, F., Prevost, M.C., Lafont, F., and Sansonetti, P. 2010. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol., 12: 530\u2013544.","DOI":"10.1111\/j.1462-5822.2009.01415.x"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Platt, F.M. 2014. Sphingolipid lysosomal storage disorders. Nature, 510: 68\u201375.","DOI":"10.1038\/nature13476"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Reczek, D., Schwake, M., Schroder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., and Saftig, P. 2007. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell, 131: 770\u2013783.","DOI":"10.1016\/j.cell.2007.10.018"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Rigante, D., Cipolla, C., Basile, U., Gulli, F., and Savastano, M.C. 2017. Overview of immune abnormalities in lysosomal storage disorders. Immunol. Lett., 188: 79\u201385.","DOI":"10.1016\/j.imlet.2017.07.004"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ron, I. and Horowitz, M. 2005. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum. Mol. Genet., 14: 2387\u20132398.","DOI":"10.1093\/hmg\/ddi240"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Rothaug, M., Zunke, F., Mazzulli, J.R., Schweizer, M., Altmeppen, H., Lullmann-Rauch, R., Kallemeijn, W.W., Gaspar, P., Aerts, J.M., Glatzel, M., Saftig, P., Krainc, D., Schwake, M., and Blanz, J. 2014. LIMP-2 expression is critical for beta-glucocerebrosidase activity and alpha-synuclein clearance. Proc. Natl. Acad. Sci. USA, 111: 15573\u201315578.","DOI":"10.1073\/pnas.1405700111"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Saito, M. and Rosenberg, A. 1985. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts. J. Biol. Chem., 260: 2295\u20132300.","DOI":"10.1016\/S0021-9258(18)89553-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sasagasako, N., Kobayashi, T., Yamaguchi, Y., Shinnoh, N., and Goto, I. 1994. Glucosylceramide and glucosylsphingosine metabolism in cultured fibroblasts deficient in acid beta-glucosidase activity. J. Biochem., 115: 113\u2013119.","DOI":"10.1093\/oxfordjournals.jbchem.a124284"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Shimizu, T., Schutt, C.R., Izumi, Y., Tomiyasu, N., Omahdi, Z., Kano, K., Takamatsu, H., Aoki, J., Bamba, T., Kumanogoh, A., Takao, M., and Yamasaki, S. 2023. Direct activation of microglia by beta-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher disease. Immunity, 56: 307\u2013319.e308.","DOI":"10.1016\/j.immuni.2023.01.008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Shin, H.-W., Morinaga, N., Noda, M., and Nakayama, K. 2004. BIG2, a guanine nucleotide exchange factor for ADP-ribosylation factors: Its localization to recycling endosomes and implication in the endosome integrity. Mol. Biol. Cell, 15: 5283\u20135294.","DOI":"10.1091\/mbc.e04-05-0388"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Barbosa, E.R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., Chen, C.M., Clark, L.N., Condroyer, C., De Marco, E.V., Durr, A., Eblan, M.J., Fahn, S., Farrer, M.J., Fung, H.C., Gan-Or, Z., Gasser, T., Gershoni-Baruch, R., Giladi, N., Griffith, A., Gurevich, T., Januario, C., Kropp, P., Lang, A.E., Lee-Chen, G.J., Lesage, S., Marder, K., Mata, I.F., Mirelman, A., Mitsui, J., Mizuta, I., Nicoletti, G., Oliveira, C., Ottman, R., Orr-Urtreger, A., Pereira, L.V., Quattrone, A., Rogaeva, E., Rolfs, A., Rosenbaum, H., Rozenberg, R., Samii, A., Samaddar, T., Schulte, C., Sharma, M., Singleton, A., Spitz, M., Tan, E.K., Tayebi, N., Toda, T., Troiano, A.R., Tsuji, S., Wittstock, M., Wolfsberg, T.G., Wu, Y.R., Zabetian, C.P., Zhao, Y., and Ziegler, S.G. 2009. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med., 361: 1651\u20131661.","DOI":"10.1056\/NEJMoa0901281"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., Rose, C., Billette de Villemeur, T., and Berger, M.G. 2017. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int. J. Mol. Sci., 18: 441.","DOI":"10.3390\/ijms18020441"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Sun, A. 2018. Lysosomal storage disease overview. Ann. Transl. Med., 6: 476.","DOI":"10.21037\/atm.2018.11.39"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Sun, Y., Florer, J., Mayhew, C.N., Jia, Z., Zhao, Z., Xu, K., Ran, H., Liou, B., Zhang, W., Setchell, K.D., Gu, J., and Grabowski, G.A. 2015. Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: Potential role in neuropathology. PLoS One, 10: e0118771.","DOI":"10.1371\/journal.pone.0118771"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Takatsu, H., Baba, K., Shima, T., Umino, H., Kato, U., Umeda, M., Nakayama, K., and Shin, H.-W. 2011. ATP9B, a P4-ATPase (a putative aminophospholipid translocase), localizes to the <i>trans<\/i>-Golgi network in a CDC50 protein-independent manner. J. Biol. Chem., 286: 38159\u201338167.","DOI":"10.1074\/jbc.M111.281006"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Takatsu, H., Tanaka, G., Segawa, K., Suzuki, J., Nagata, S., Nakayama, K., and Shin, H.W. 2014. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane. J. Biol. Chem., 289: 33543\u201333556.","DOI":"10.1074\/jbc.M114.593012"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Tan, Y.L., Genereux, J.C., Pankow, S., Aerts, J.M., Yates, J.R., 3rd, and Kelly, J.W. 2014. ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher\u2019s disease. Chem. Biol., 21: 967\u2013976.","DOI":"10.1016\/j.chembiol.2014.06.008"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Varela, A.R.P., Couto, A.S., Fedorov, A., Futerman, A.H., Prieto, M., and Silva, L.C. 2016. Glucosylceramide reorganizes cholesterol-containing domains in a fluid phospholipid membrane. Biophys. J., 110: 612\u2013622.","DOI":"10.1016\/j.bpj.2015.12.019"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Varela, A.R.P., Ventura, A.E., Carreira, A.C., Fedorov, A., Futerman, A.H., Prieto, M., and Silva, L.C. 2017. Pathological levels of glucosylceramide change the biophysical properties of artificial and cell membranes. Phys. Chem. Chem. Phys., 19: 340\u2013346.","DOI":"10.1039\/C6CP07227E"},{"key":"46","doi-asserted-by":"publisher","unstructured":"Wang, F., Gomez-Sintes, R., and Boya, P. 2018. Lysosomal membrane permeabilization and cell death. Traffic, 19: 918\u2013931.","DOI":"10.1111\/tra.12613"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Zama, K., Hayashi, Y., Ito, S., Hirabayashi, Y., Inoue, T., Ohno, K., Okino, N., and Ito, M. 2009. Simultaneous quantification of glucosylceramide and galactosylceramide by normal-phase HPLC using O-phtalaldehyde derivatives prepared with sphingolipid ceramide N-deacylase. Glycobiology, 19: 767\u2013775.","DOI":"10.1093\/glycob\/cwp047"}],"container-title":["Cell Structure and Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/csf\/49\/1\/49_23066\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:49:08Z","timestamp":1715575748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/csf\/49\/1\/49_23066\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1247\/csf.23066","relation":{},"ISSN":["0386-7196","1347-3700"],"issn-type":[{"value":"0386-7196","type":"print"},{"value":"1347-3700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23066"}}